The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin.
about
HIV-1 Vif and APOBEC3G: multiple roads to one goalCyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase MachineryRegulation of Apobec3F and human immunodeficiency virus type 1 Vif by Vif-Cul5-ElonB/C E3 ubiquitin ligase.Mutations in the highly conserved SLQYLA motif of Vif in a simian-human immunodeficiency virus result in a less pathogenic virus and are associated with G-to-A mutations in the viral genome.Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15.The HDAC6/APOBEC3G complex regulates HIV-1 infectiveness by inducing Vif autophagic degradation.MDM2 is a novel E3 ligase for HIV-1 Vif.Defining HIV-1 Vif residues that interact with CBFβ by site-directed mutagenesis.HIV-1, ubiquitin and ubiquitin-like proteins: the dialectic interactions of a virus with a sophisticated network of post-translational modifications.Role of the single deaminase domain APOBEC3A in virus restriction, retrotransposition, DNA damage and cancer.Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.HIV-1 Vif: a guardian of the virus that opens up a new era in the research field of restriction factorsAnalysis of the N-terminal positively charged residues of the simian immunodeficiency virus Vif reveals a critical amino acid required for the antagonism of rhesus APOBEC3D, G, and H.Viral subversion of APOBEC3s: Lessons for anti-tumor immunity and tumor immunotherapy.APOBEC3G expression is restricted to epithelial cells of the proximal convoluted tubules and is not expressed in the glomeruli of macaques.
P2860
Q24564072-BB5AE7EE-7E32-42EA-9795-325BF947B1FFQ33567848-57AB45B0-A273-4E88-9877-863D4CCFD2F2Q33908716-AA3183CD-29E6-402A-B814-76AE98E2B40CQ33925040-04C2603A-E2A1-4725-B976-5710786D55FDQ34335062-70393471-A1E1-4F69-B092-61484F1EB935Q35776289-3237756E-5D61-49EB-B16C-E80999E3591EQ37069041-07BD620C-B485-4C96-AEFB-C78ED0C10C91Q37605560-D5851631-6399-442C-9695-B08F829AA3A6Q37970436-EA660D1E-BD7F-467C-B637-50C302B87DF1Q38613375-58D33CF7-1448-4AE3-B63D-501ED780B26CQ38739726-9FFEA674-C13F-42F4-A42C-D29FB44FBFF0Q39463408-49F47E78-BE7E-49D9-B6CE-EA7212FE9FC5Q41892602-D2B92968-6D60-4213-8E53-A6A4B2C74583Q47568875-9593CCCA-82CB-424B-93DB-909EC409B4D7Q54580515-B8192F2E-49A3-47E0-AA72-4ACC3C083FC7
P2860
The Vif protein of human immunodeficiency virus type 1 is posttranslationally modified by ubiquitin.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
The Vif protein of human immun ...... ionally modified by ubiquitin.
@en
type
label
The Vif protein of human immun ...... ionally modified by ubiquitin.
@en
prefLabel
The Vif protein of human immun ...... ionally modified by ubiquitin.
@en
P2093
P1476
The Vif protein of human immun ...... ionally modified by ubiquitin.
@en
P2093
Gilles Bessou
Marc Douaisi
Marianne Courcoul
Robert Vigne
Sylvie Dussart
Yohann Duverger
P356
10.1016/J.BBRC.2004.01.023
P577
2004-02-01T00:00:00Z